• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation and optimization of a commercial influenza A blocking ELISA for research and surveillance of mallards

tetano

Editor, Senior Moderator
J Virol Methods. 2015 Nov 29. pii: S0166-0934(15)00382-1. doi: 10.1016/j.jviromet.2015.11.021. [Epub ahead of print]
[h=1]Evaluation and optimization of a commercial influenza A blocking ELISA for research and surveillance of mallards.[/h] Shriner SA[SUP]1[/SUP], VanDalen KK[SUP]2[/SUP], Root JJ[SUP]2[/SUP], Sullivan HJ[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The availability of a validated commercial assay is an asset for any wildlife investigation. However, commercial products are often developed for use in livestock and are not optimized for wildlife. Consequently, it is incumbent upon researchers and managers to apply commercial products appropriately to optimize program outcomes. We tested more than 800 serum samples from mallards for antibodies to influenza A with the IDEXX AI MultiS-Screen Ab test to evaluate assay performance. Applying the test per manufacturer's recommendations resulted in good performance with 84% sensitivity and 100% specificity. However, performance was improved to 98% sensitivity and 98% specificity by increasing the recommended cut-off. Using this alternative threshold for identifying positive and negative samples would greatly improve sample classification, especially for field samples collected months after infection when antibody titers have waned from the initial primary immune response. Furthermore, a threshold that balances sensitivity and specificity reduces estimation bias in seroprevlanece estimates.
Copyright ? 2015. Published by Elsevier B.V.


PMID: 26645952 [PubMed - as supplied by publisher]
 
Back
Top Bottom